Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Rare Condensate Coronas and Biomolecular Transfer
2026-11-10
A 2026 Nature Materials study describes a rare class of nanoparticle–cell hybrids in which a cell-derived condensate corona carries proteins and RNAs between cells. The findings support a mechanistic model involving selective re-export, endosomal detachment and intracellular redistribution, while leaving major questions about event frequency, lineage, cargo functionality and applicability beyond the studied cellular systems.
H-89 and the Wnt–Bone Metabolic Axis
2026-11-10
The evidence places PKA at an upstream branch of Wnt-driven O-GlcNAcylation and glycolytic remodeling in osteoblastogenesis. H-89 is relevant as a pharmacological probe of that branch, but the strongest causal evidence concerns genetic perturbation, PDK1 modification, metabolism, and tissue-level bone outcomes rather than H-89 alone.
How Condensate Coronas Transfer RNA
2026-11-09
A rare subset of internalized nanoparticles can acquire cell-derived condensate coronas that preserve proteins and RNA, then transfer those cargos between cells. The evidence supports a distinct, endosome-responsive route of biomolecular transport while leaving its frequency, physiological importance and generality unresolved.
Targeted Expression in Rabbit Pharming: What Is Proven?
2026-11-09
A 2025 study reported unusually high reporter-protein concentrations after placing a transgene at the rabbit CSN2 locus, but the result is a small proof-of-concept rather than a definitive comparison with conventional pharming. The key unresolved questions concern reproducibility, protein-specific performance, total production, animal biology, and whether the apparent advantage is caused by locus targeting, promoter choice, genetic background, or their combination.
How Condensate Coronas Re-route Nanoparticle Cargo
2026-11-08
A cell-biology study describes a rare pathway in which internalized synthetic nanoparticles acquire a cell-derived condensate layer, are re-exported, and later release protein and RNA cargo into intracellular compartments. The evidence supports a recognition-dependent trafficking mechanism, while remaining bounded by heterogeneous particle populations, detection limits for RNA integrity, and the use of cultured-cell models.
Condensate Coronas and Nanoparticle Trafficking
2026-11-07
A mechanistic cell-biology study describes how a rare subset of synthetic nanoparticles acquires a cell-derived condensate corona, separates from its core inside endosomal compartments, and transfers protein and RNA cargo into intracellular locations. Comparison with extracellular vesicles and a recognition perturbation support a distinct, interaction-dependent trafficking model, while leaving important questions about population heterogeneity and generalizability.
How Condensate Coronas Transfer Biomolecules
2026-11-06
A Nature Materials study describes rare synthetic nanoparticle–cell condensate hybrids that export intact proteins and RNAs between cells. Its imaging, molecular profiling and functional reporter data support a model in which condensate–endosome interactions govern intracellular access, while leaving important questions about event frequency, physiological relevance and generalizability unresolved.
Condensate Coronas and Nanoparticle Cargo Transfer
2026-11-06
A mechanistic cell-biology study describes how a rare subset of synthetic nanoparticles acquires a cell-derived condensate corona, separates from its core in endosomal compartments, and transfers proteins and RNA-associated material to intracellular destinations. Comparisons with extracellular vesicles and recognition perturbations support a model in which molecular interactions influence intracellular access, while the findings remain specific to the tested cultured-cell systems.
HNRNPU Lactylation and Cervical Cancer Metabolism
2026-11-05
A mechanistic analysis of how HNRNPU K181 lactylation may connect lactate accumulation with PHGDH expression, serine metabolism, redox balance, and cervical-cancer growth. It also clarifies the separate interpretive role of (R)-MG132, the low-activity MG-132 enantiomer, as a proteasome-control compound rather than evidence for the lactylation pathway.
How Condensate Coronas Re-route Nanoparticle Cargo
2026-11-05
A cell-biology study describes a rare pathway in which internalized synthetic nanoparticles acquire cell-derived condensate coronas, are re-exported, and can redistribute biomolecular cargo beyond conventional degradative compartments. The findings distinguish these complexes from extracellular vesicles while linking intracellular recognition to condensate separation and cellular access.
When Context Changes a Nanoparticle Result
2026-11-04
A result in nanobiology can mean different things depending on the material architecture, cell model, comparator, and readout. The reported condensate–nanoparticle study illustrates why rare-event selection, intracellular trafficking, and functional assays must be interpreted together rather than treated as interchangeable evidence.
Condensate Coronas Reframe Nanoparticle Trafficking
2026-11-04
A mechanistic cell-biology study describes how a subset of synthetic nanoparticles acquires a cell-derived condensate corona, is re-exported, and transfers biomolecular cargo through intracellular routes that differ from conventional lysosomal processing.
When Context Changes What a Result Means
2026-11-03
A nanoparticle-associated signal can represent cargo transfer, compartmental retention, or a rare biological subpopulation. This editorial examines how model choice, particle history, comparator selection and readout determine what the reported findings establish—and what they do not.
Condensate Coronas and Nanoparticle Trafficking
2026-11-03
A mechanistic cell-biology study describes how a rare subset of synthetic nanoparticles acquires a cell-derived biomolecular condensate corona, is re-exported, and can redistribute protein and RNA cargo after uptake. The findings distinguish these hybrid complexes from extracellular vesicles while linking condensate–cell recognition to intracellular trafficking.
How Condensate Coronas Transfer Biomolecular Cargo
2026-11-02
A literature-focused analysis of how rare nanoparticle–condensate hybrids acquire cellular proteins and RNAs, move between cells, and gain intracellular access—while clarifying what the study does and does not establish.